Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$BNTX Q4 '24 Earnings Results & Recap BioNTech's Q4 2024 EPS was €1.08, beating the estimated €0.38, while revenue was approximately €1.2B, beating the estimated €1.14B; the company anticipates revenue between €1.7B and €2.2B in 2025 and significant progress in its oncology pipeline, but faces challenges in the metastatic melanoma setting.
8

Since Post

Full Details

Advertisement|Remove ads.